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Cd14 and Alpk1 both encode pathogen recognition receptors and are known candidate genes for affecting severity in inflammatory
bowel diseases. CD14 acts as a coreceptor for bacterial lipopolysaccharide (LPS), while ALPK1 senses ADP-D-glycero-beta-D-
manno-heptose, a metabolic intermediate of LPS biosynthesis. Intestinal barrier integrity can be influenced by CD14, whereas to
date, the role of ALPK1 in maintaining barrier function remains unknown. We used colon-derived 3D organoids, first
characterised for growth, proliferation, stem cell markers, and expression of tight junction (TJ) components using qPCR and
immunohistochemistry. They showed characteristic crypt stem cells, apical shedding of dead cells, and TJ formation.
Afterwards, organoids of different genotypes (WT, Il10-/-, Cd14-/-, and Alpk1-/-) were then stimulated with either LPS or
Escherichia coli Nissle 1917 (EcN). Gene expression and protein levels of cytokines and TJ components were analysed. WT
organoids increased expression of Tnfα and tight junction components. Cd14-/- organoids expressed significantly less Tnfα and
Ocln after LPS stimulation than WT organoids but reacted similarly to WT organoids after EcN stimulation. In contrast,
compared to WT, Alpk1-/- organoids showed decreased expression of different TJ and cytokine genes in response to EcN but not
LPS. However, Western blotting revealed an effect of ALPK1 on TJ protein levels. These findings demonstrate that Cd14, but
not Alpk1, alters the response to LPS stimulation in colonic epithelial cells, whereas Alpk1 is involved in the response upon
bacterial challenge.
1. Introduction
Inflammatory bowel disease (IBD) onset involves the inter-
play between microbiota, environmental conditions, genetic
factors, and a disrupted intestinal barrier [1]. Several mouse
models of IBD have been established [2] including the well-
studied Il10 (interleukin-10) deficiency model. This model
is characterised by a dysregulated immune response to
enteric microflora leading to the onset of colitis through a
disrupted barrier due to increased levels of interferon gamma
and tumor necrosis factor alpha (TNFα) [3]. Using the Il10-/-
mouse model and quantitative trait locus (QTL) analyses,
several studies have identified genetic loci associated with
susceptibility to IBD. These studies revealed ten cytokine
deficiency-induced colitis susceptibility (Cdcs) loci and candi-
date genes with a potential influence on colitis onset [4–9].
One of these genes is Cd14 (Cluster of differentiation 14) in
the Cdcs6 locus located on chromosome 18 [7]. CD14 acts
as a coreceptor of Toll-like receptor (TLR) 4 and is directly
involved in the detection of lipopolysaccharide (LPS) and
activation of NF-κB [10]. In previous studies, our group dem-
onstrated that CD14 has a protective function on barrier
integrity in a dextran sodium sulfate- (DSS-) induced acute
colitis mouse model [11]. We also showed that in wild-type
(WT) but not in Cd14-/- mice, monoassociation with Escher-
ichia coli Nissle 1917 (EcN) leads to increased expression of
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tight junction (TJ) components, associated with protection
against bacterial translocation [12].
Another candidate gene revealed by these QTL studies is
Alpk1 (alpha-protein kinase 1) which is located on chromo-
some 3 in the Cdcs1 locus [4, 5]. Knockout of the Alpk1 gene
in mice was recently shown to lead to severe colitis when
infected with Helicobacter hepaticus [13]. ALPK1 functions
as a pattern recognition receptor for adenosine diphosphate-
heptose (ADP-Hep), a precursor of LPS [14]. In human epi-
thelial cells, ADP-Hep of Gram-negative bacteria activates
NF-κB-dependent inflammatory interleukin-8 (IL-8) secre-
tion via an ALPK1-TIFA-TRAF6 axis [15]. As mice lack a
functional Il-8 gene, the chemokines CXCL1, CXCL2, and
CXCL5 are regarded as functional homologues [16].
To study the specific impact of Il10, Cd14, and Alpk1 on
intestinal epithelial cell (IEC) response to bacterial stimula-
tion, we used colonic organoid cultures derived from isolated
intestinal stem cells (ISCs) [17]. These ISCs can differentiate
into all colonic epithelial lineages including colonocytes, gob-
let cells, and several enteroendocrine cell types [18]. In the
present study, colonic organoids of different knockout mouse
strains were stimulated with LPS or EcN and the expression
of proinflammatory mediators and tight junction compo-
nents was determined. Here, we report that IEC Cd14 and
Alpk1 both affect cytokine and TJ component expression
upon bacterial challenge.
2. Materials and Methods
2.1. Mice. This study was conducted in accordance with
German animal protection law and with the European
Directive 2010/63/EU. All experiments were approved
by the Local Institutional Animal Care (File: 2015/78).
Phenotypically healthy female and male, 8 to 18 weeks
old, C57BL/6J (WT), C57BL/6J.129P2-Il10tm1Cgn (B6-
Il10-/-), C57BL/6J.129S1-Cd14tm1Smg (B6-Cd14-/-), C57B
L/6N (Alpk1+/+), C57BL/6N-Alpk1em2Wtsi (Alpk1-/-), and
B6.129P2-Lgr5tm1(cre/ERT2)Cle/J (Lgr5-eGFP+/-) mice were
obtained from the Central Animal Facility (Hannover Medi-
cal School, Hannover, Germany). All mice were housed
under specific pathogen-free conditions in individually venti-
lated cages.
2.2. Preparation of Organoids. The protocol was based on
Mahe et al. [18]. Mice were sacrificed by CO2 inhalation
followed by cervical dislocation at an age of 10-14 weeks.
The entire colon was flushed and washed with sterile, ice-
cold Dulbecco’s phosphate-buffered saline (DPBS) in a sterile
environment. All further steps were performed on ice. Tis-
sues were opened lengthwise and cut into small pieces,
washed several times with DPBS, transferred into crypt che-
lating buffer (CCB) (DPBS containing 0.5M EDTA), and
incubated for 30 minutes on a rocking platform. After wash-
ing with CCB, colon pieces were transferred into dissociation
buffer (DB) (DPBS containing 54.9mM sorbitol and
43.4mM sucrose) and mixed thoroughly. Cell suspensions
were filtered and centrifuged, and cells were resuspended in
an appropriate volume of Matrigel® membrane matrix
(Corning™, New York, USA) (Matrigel®) to yield approxi-
mately 1000 crypts/ml. Fifty μl of the cell-Matrigel® mixture
was carefully pipetted into the centre of each well of a 24-well
plate, incubated for 30 minutes at 37°C for solidification, and
overlaid with 500μl organoid growth media (DMEM, high
glucose, GlutaMAX™, pyruvate (Thermo Fisher Scientific,
Massachusetts, USA)) supplemented with 50% L-WRN-
supernatant (ATCC® CRL3276™ in DMEM, high glucose,
GlutaMAX™, pyruvate plus 10% fetal calf serum), 1x N2
(Invitrogen, Carlsbad, USA), 1x B27 (Invitrogen, Carlsbad,
USA), 50 ng/μl recombinant mouse epidermal growth factor
(Sigma-Aldrich, St. Louis, USA), 10μM Y-27632 (Tocris,
Bristol, UK), and 1x Cellshield (Biochrom, Berlin, Germany).
Organoids were cultured at 37°C with 5% CO2. Media was
exchanged every 3-4 days.
2.3. Organoid Kinetics. Matrigel® was dissolved using ice-
cold DPBS, and crypts were separated by drawing the sus-
pension up once through a syringe using a 27G 1/2″ needle.
Cells were washed and seeded into fresh Matrigel®, which
was allowed to solidify for 30 minutes at 37°C, and afterwards
overlaid with 500μl organoid growth media. Pictures were
taken on days 1, 3, 5, 7, 9, 11, and 13 after seeding. At each
time point, three samples were obtained for RNA isolation
by pooling two wells of a 24-well plate for each sample.
2.4. Hematoxylin and Eosin (H&E) Staining. Matrigel®-
embedded organoids were embedded in 4% agarose, fixed
with 4% formalin overnight, dehydrated, and cut into 4μm
sections. A standard H&E staining was performed.
2.5. Immunofluorescence Staining. Matrigel®-embedded
organoids were whole mount stained. Therefore, they were
fixed for 1 h with 4% formalin. Autofluorescence was
quenched via incubation with NH4Cl for 1 h. Permeabilisa-
tion and blocking were performed for 1.5 h with 0.5%
Triton-X100 and 10% horse serum in DPBS. Organoids were
stained with rat anti-EpCAM/CD326-FITC, rabbit anti-
occludin, rabbit anti-tight junction protein 1 (TJP1; also
known as zonula occludens 1, ZO-1), rabbit anti-claudin 8
(all Invitrogen, Carlsbad, USA), or rabbit anti-Ki67 (Abcam,
Cambridge, UK). Unconjugated antibodies were visualised in
a second step by a goat anti-rabbit DyLight 488 antibody
(BioLegend, San Diego, USA). Primary and secondary anti-
bodies were diluted in 0.1% Triton-X100, 10% horse serum
in DPBS, and incubated overnight at 4°C. Images were
acquired using a confocal TCS SP5microscope system (Leica,
Wetzlar, Germany).
2.6. TUNEL Staining. Preparation of Matrigel®-embedded
organoids was performed as per immunofluorescence stain-
ing. TUNEL staining was performed using an In Situ Cell
Death Detection Kit, Fluorescein (Roche, Basel, Switzerland),
according to the manufacturer’s instructions.
2.7. Stimulation with LPS. As we wanted to activate CD14-
dependent signalling, a low dose of LPS was necessary as it
is known that higher concentrations of LPS result in CD14-
independent TLR4 signalling [19, 20]. In previous experi-
ments using the mouse epithelial cell line CMT93, we tested
different LPS concentrations and time points [11]. In our
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hands, 0.1μg/ml and 6 hours were the best concentration and
incubation time to measure CD14-dependent cytokine
induction. After 10 days of growth, colonic organoids were
stimulated with LPS (Sigma-Aldrich, St. Louis, USA) as
described previously [11]. In brief, growth media was
removed and replaced with 500μl fresh growth media with-
out Cellshield and containing either 0.1μg/ml LPS or no
LPS as the control. After 6 hours of incubation at 37°C and
5% CO2, media was removed and the Matrigel® was dis-
solved in ice-cold DPBS. Two to 6 wells were pooled, and
cells were centrifuged, resuspended in RNA Quick-RNA™
Micro Prep Kit Lysis Buffer (Zymo Research, Irvine, USA),
and stored at -80°C for later RNA isolation.
2.8. Stimulation with E. coli Nissle 1917. An ampicillin-resis-
tant, GFP-expressing E. coli Nissle 1917 strain (EcN) was
grown at 37°C shaking in lysogeny broth (LB) media contain-
ing 100μg/ml ampicillin until an OD600 of 1.0 was reached.
As we wanted to compare LPS- and EcN-stimulated orga-
noids, we chose the same incubation time for both treat-
ments. Moreover, in preliminary experiments with our WT
organoids, 6 hours of EcN stimulation reproducibly resulted
in significant increases in both TNFα gene expression and
protein production compared to unstimulated cells. The bac-
terial suspension was diluted 1 : 25 in Cellshield-free orga-
noid growth media. Media of organoids grown for 10 days
was removed and replaced with the bacteria-containing
growth media and incubated for 6 hours at 37°C and 5%
CO2. Media was removed, and organoid cells were harvested
for RNA isolation according to the LPS stimulation protocol.
2.9. RNA Isolation. RNA isolation was performed with RNA
Quick-RNA™ Micro Prep Kit (Zymo Research, USA)
according to the manufacturer’s instructions.
2.10. Quantitative Real-Time PCR (qPCR). For quantification
of gene expression after stimulation, up to 1μg RNA was
used for cDNA synthesis using QuantiTect® Reverse Tran-
scription Kit (Qiagen®, Hilden, Germany) according to the
manufacturer’s instructions. For qPCR analysis, a QuantStu-
dio™ 6 Flex Real-Time PCR System (Applied Biosystems™,
Foster City, USA) was used. qPCR was performed using
either a TaqMan®-based assay (Actb: Mm00607939_s1; Tnfα:
Mm00443258_m1; Mki67: Mm01278617; LgR5: Mm00438
890_m1; Smoc2: Mm00491553_m1; Clca4b: Mm01616360_
m1; Applied Biosystems®, Foster City, USA) or SYBR™
Green-Based QuantiTect® Primer Assays (Actb: Mm_Actb_
2_SG; Cldn4: Mm_Cldn4_1_SG; Cldn8: Mm_Cldn8_1_SG;
Ocln: Mm_Ocln_1_SG; Tjp1: Mm_Tjp1_1_SG; Cxcl1: Mx_
Cxcl1_1_SG; Cxcl2: Mx_Cxcl2_1_SG; Cxcl5: Mm_Cxcl5_2_
SG; Qiagen®, Hilden, Germany). Each sample was measured
in triplicate. Actb was used as endogenous reference control
gene. Relative gene expression was calculated using the
2−ΔCt method.
2.11. Immunoassays. TNFα was quantified in the superna-
tants of LPS- and EcN-stimulated organoids using an ELISA
MAX™ Deluxe Set Mouse TNFα (BioLegend, San Diego,
USA), according to the manufacturer’s instructions. Samples
and standards were prepared in duplicate and measured at
450 nm with a plate reader (VICTOR™ X3, PerkinElmer,
Waltham, MA, USA). CXCL1, CXCL2, and CXCL5 were
quantified using a multiplex immunoassay (ProcartaPlex,
Life Technologies, Carlsbad, USA) according to the manu-
facturer’s instructions. Concentrations were determined by
parallel standard curves for each parameter.
2.12. Western Blot Analysis. Organoids were analysed for TJ
expression by Western blot analysis after treatment with
LPS or EcN. Organoids were homogenized with a tissue
homogenisator (Ultra Turrax, IKA®-Werke GmbH & Co.
KG). Proteins were extracted and separated by sodium dode-
cyl sulfate polyacrylamide gel electrophoresis, transferred to
a nitrocellulose membrane, and immunoblotted using pri-
mary antibodies against occludin, claudin8, zonula
occludens-1 (Invitrogen), and claudin4 (Abcam). Immuno-
blotting for GAPDH (GenScript USA Inc., NJ, USA) was
used as an internal control. After incubation with the second-
ary antibody (donkey anti-rabbit IgG (HRP); Abcam), the
membrane was developed with a chemiluminescence solu-
tion (Bio-Rad Laboratories, Hercules, California, USA) and
images were acquired using a ChemiDoc™ Touch Imaging
System (Bio-Rad). Blot analysis was performed via ImageJ
software (open source).
2.13. Statistical Analysis. All statistical analyses were per-
formed using GraphPad Prism6® software (San Diego,
USA). Values represent the means with 95% CI or SEM. All
values were normalized to the corresponding unstimulated
controls in each independent experiment. Accordingly,
unstimulated control values were calculated to a value of 1.
When two conditions were compared, unpaired t-tests were
performed. In other cases, one-way analysis of variances
followed by Dunnett’s multiple comparison tests were used
to compare values of stimulated samples of all three knock-
out genotypes to WT organoids. In the case of unequal vari-
ances, a Brown-Forsythe and Welch ANOVA test was
performed. P < 0:05 was considered significant. ∗ indicates
P < 0:05, ∗∗ indicates P < 0:01, ∗∗∗ indicates P < 0:001,
and ∗∗∗∗ indicates P < 0:0001.
3. Results
3.1. Colonic Organoids Expand and Differentiate until Day 10
before They Degrade. After separation of organoids using a
syringe, pictures were taken for growth documentation
(Figure 1(a)). Already on day 1, we observed small colono-
spheres which increased in size until day 3. At day 5, most
of the colonospheres started to form crypts around the circu-
lar centre, indicating a colonoid state. Dead cells shed into
the lumen. On day 7, only minor changes were observed
compared to day 5. On day 9, colonic organoids were evenly
distributed and developed in the Matrigel®. Starting on day
11, organoids began to break open, resulting in dead cells
and debris located outside the colonic organoids. Finally,
on day 13, most organoids were disintegrated. At each time
point, RNA was isolated from organoids for a later gene
expression analysis. RNA concentrations increased until
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day 5 and remained stable until day 11, after which they rap-
idly decreased until day 13.
To characterise cell proliferation within organoids, Ki67
expression was determined on the mRNA level by qPCR.
An increase in Ki67 gene expression occurred up to day 5
with a drop in expression at day 7. After a media change on
day 7, Ki67 expression increased and kept increasing until
another media change on day 10, after which expression
became quite variable. This resulted in widely distributed
expression values on day 11. On day 13, Ki67 mRNA was
no longer detectable in any organoids. Gene expression of
the IEC genes Smoc2 and LgR5 was analysed and showed a
similar expression pattern as Ki67. In contrast, gene expres-
sion of the proliferation inhibitor and epithelial differentia-
tion marker Clca4b [21] was low and mostly stable up to
day 9, after which expression increased until day 13. Further-
more, gene expression of TJ components such as Ocln, Tjp1,
Cldn4, and Cldn8 was analysed. Similar expression levels
were detectable between day 1 and day 13 for Ocln and
Tjp1, while Cldn4 increased and Cldn8 decreased rapidly on
day 13 (Figure 1(d)). Thus, we decided to perform all further
experiments using organoids after 10 days of growth, where
the morphology showed crypts and the proliferation level
was still high.
3.2. Colonic Organoids Represent Fully Differentiated Colon
Epithelium. We performed H&E staining on 10-day-old
organoid sections to analyse the differentiation and growth
status of the IECs (Figure 2(a)). Around the circular lumen,
a fully differentiated epithelium with crypts formed, consist-
ing primarily of enterocytes and mucus-containing goblet
cells. A few LGR5-positive cells (Figure 2(b)) were present
at the base of crypts, whereas high amounts of Ki67-
positive cells (Figure 2(c)) were located at the base and sides
of crypt and were not found elsewhere in the organoids. Dead
cells collected in the lumen as confirmed by whole mount
TUNEL staining (Figure 2(d)). The organoid cell layer
stained positive for epithelial cell adhesion molecule
(EPCAM or CD326) which confirmed these cells as epithelial
cells (Figure 2(e)). These cells were also positive for the intra-
cellular TJ proteins occludin (OCLN) (Figure 2(f)), tight
junction protein 1 (TJP1) (Figure 2(g)), and claudin-8
(CLDN8) (Figure 2(h)).
3.3. Decreased Expression of Tight Junction Components and
Proinflammatory Response in Cd14-/- Epithelial Cells upon
LPS Stimulation. After 6 hours of LPS stimulation, RNA or
protein samples were taken from the organoids and expres-
sion levels of different genes involved in tight junctions (Ocln,
Tjp1, Cldn4, and Cldn8) (Figure 3 and Supplemental
Figure 1) and immune response (Tnfα, Cxcl1, Cxcl2, and
Cxcl5) were analysed (Figure 4). To adjust batch effects, all
values were normalized to the corresponding unstimulated
controls in each independent experiment. Compared to
WT organoids, Ocln expression significantly increased in
Il10-/- organoids after exposure to LPS but was significantly
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Figure 1: Growth pattern analysis of C57BL/6J colonic organoid culture over time after separation and seeding into new Matrigel®. (a)
Representative light phase contrast images. (b) RNA concentrations (n = 5). (c) Relative quantification of expression levels of Ki67, Lgr5,
Smoc2, and Clca4b (n = 5). Individual values are represented with the mean and standard deviation. (d) Relative quantification of
expression levels of Ocln, Tjp1, Cldn4, and Cldn8 (n = 5). Individual values are represented with the mean and standard deviation.
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decreased in Cd14-/- organoids after LPS stimulation
(Figure 3(a)). Western blot analysis of OCLN showed no
differences in all organoids after 6 h of LPS stimulation
(Figure 3(b)). Gene and protein expression of Tjp1 was not
altered in any of the organoids after LPS challenge
(Figures 3(a) and 3(b)). LPS exposure significantly
increased Cldn4 expression in WT and Il10-/- and slightly
in Alpk1-/- organoids (Figure 3(a)). In Cd14-/- organoids,
Cldn4 expression decreased slightly upon LPS exposure.
These differences were not detectable on protein level
(Figure 3(b)). As for Cldn8, expression levels remained
unchanged for all genotypes (Figure 3(a)); however,
CLDN8 expression was increased in Alpk1-/- organoids
after LPS stimulation (Figure 3(b)).
Upon LPS stimulation, gene expression of proinflamma-
tory Tnfαwas increased in all organoids, but this increase was
significantly less in Cd14-/- organoids compared to WT orga-
noids (Figure 4(a)). Protein levels of TNFa proteins also
increased in all organoids especially in Il10-/- epithelial cells.
In contrast, TNFα secretion was not increased in Cd14-/- epi-
thelial cells after LPS stimulation (Figure 4(a)). Chemokines
Cxcl1, Cxcl2, and Cxcl5 were increased after LPS stimulation
in both investigated organoid genotypes, WT and Alpk1-/-
(Figures 4(b)–4(d)). However, multiplex analysis of CXCL1,
CXCL2, and CXCL5 revealed only an increase in WT orga-
noids. Alpk1-/- epithelial cells showed only a modest increase
in chemokine expression. Thus, LPS triggers a proinflamma-
tory effect in all observed organoids but had lower effects in
Cd14-/- and Alpk1-/- epithelial cells. Additionally, expression
of TJ components Ocln and Cldn4 is affected by LPS in
Cd14-/- organoids and CLDN8 seems to be altered in Alpk1-
/- epithelial cells.
3.4. Alpk1 Deficiency Affects Tight Junction Component
Expression after E. coli Nissle 1917 Infection of Colonic
Organoids. After 6 hours of EcN stimulation, gene and pro-
tein expression of tight junctions and inflammatory cyto-
kines was measured (Figures 5 and 6 and Supplemental
Figure 1). WT and Il10-/- organoids showed no changes in
Ocln and Tjp1 expression compared to uninfected controls
(Figures 5(a) and 5(b)); Ocln expression was significantly
increased in Cd14-/- organoids (Figure 5(a)). Upon EcN
infection, Alpk1-/- organoids had slight but not statistically
significant decreased Ocln expression (Figure 5(a)).
However, Western blot analysis showed an increased
OCLN level compared to WT organoids (Figure 5(b)).
Significantly reduced Tjp1 expression was measured in

















Figure 2: Staining of 10-day-old colonic organoids. (a) Hematoxylin and eosin staining. (b) Lgr5 of Lgr5-eGFP+/- mice. (c)
Immunohistological staining of Ki67. (d–g) Immunofluorescence staining for (d) TUNEL, (e) epithelial cell adhesion molecule, (f)
occludin, (g) tight junction protein 1, and (h) claudin-8.
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TJP1 levels in all genotypes (Figures 5(a) and 5(b)). Cldn4
expression significantly increased upon EcN exposure in all
genotypes although only increased CLDN4 expression was
determined in Alpk1-/- organoids (Figures 5(a) and 5(b)).
Cldn8 expression was significantly elevated in WT, Il10-/-,
and Cd14-/- organoids upon EcN stimulation but notably
not in Alpk1-/- organoids (Figures 5(a) and 5(b)). However,
increased protein expression was measured in Alpk1-/- epi-
thelial cell (Figure 5(b)).
After EcN stimulation, Tnfα/TNFα expression was ele-
vated for all organoids, but this increase was significantly
lower in Cd14-/- compared to WT organoids (Figure 6(a)).
Expression of Cxcl1, Cxcl2, and Cxcl5 was increased upon
EcN exposure in WT and Alpk1-/- organoids, but the
increases in Cxcl1 and Cxcl5 expression were significantly
lower in Alpk1-/- organoids compared to WT organoids
(Figures 6(b)–6(d)).
No difference in chemokine secretion between Alpk1-/-
organoids and WT epithelial cells was observed in multiplex
analysis of supernatants (Figures 6(b)–6(d)).
Together, our data show (i) decreased Ocln and Tnfα
gene expression in LPS-stimulated Cd14-/- organoids com-
pared to WT epithelial cells; (ii) increased CLDN8 protein
expression after LPS stimulation in Alpk1-/- cells; (iii)
decreased Cldn8, Cxcl1, and Cxcl5 gene expression and
increased protein expression of TJ components such as
CLDN4, CLDN8, and OCLN in EcN-stimulated Alpk1-/-
organoids compared to stimulated WT organoids; and (iv)
less Tnfα/TNFα production in Cd14-/- cells compared to
WT epithelial cells. In conclusion, these data indicate that
Cd14, but not Alpk1, alters the response to LPS stimulation
in colonic epithelial cells, whereas Alpk1 is more involved
in the proinflammatory response to bacterial challenge.
4. Discussion
In the present study, we utilized colon-derived 3D organoids
derived fromWT, Il10-/-, Cd14-/-, and Alpk1-/- knockout mice
to investigate the response to either purified LPS or whole
Gram-negative bacteria. We show for the first time a role
for ALPK1 in TJ component regulation after infection with
the Gram-negative bacteria EcN. In addition, our results cor-
roborate the role of CD14 in LPS-triggered proinflammatory
and TJ component responses [11]. Although there are
reports of Il10 being expressed in IECs [22], IL10 itself is pri-
marily produced by immune cells where it functions to regu-
late the intestinal homeostasis and barrier integrity via its
anti-inflammatory effects [23, 24]. In our study, the absence
of IL10 did not alter the response of colonic organoids to
EcN compared to WT cells.
There are several variations described to culture, sepa-
rate, and passage 3D organoids which result in different
periods of growth and differentiation [18, 25, 26]. Our iso-
lated crypt stem cells developed into colonospheres within
24 hours. The observed growth correlated with an increase
in RNA concentration, proliferation, and expression of stem
cell genes in the first 5 days. Organoid growth and differenti-
ation are highly dependent on the supplied media
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Figure 3: Expression of tight junction after LPS stimulation. Organoids of different genotypes were stimulated with LPS for 6 hours. Change
in tight junction component gene and protein expression was analysed and compared to wild type (WT). Values were normalized to
unstimulated controls within each genotype in each experiment and represented the means with 95% CI and SEM. Unstimulated: WT n =
3‐13, Cd14-/- n = 3‐14, Il10-/- n = 3‐9, and Alpk1-/- n = 3‐6. Stimulated: WT n = 2‐17, Cd14-/- n = 3‐15, Il10-/- n = 3‐11, and Alpk1-/- n = 3‐6.
(a) Gene expression. RQ= relative quantification. (b) Detection of TJ proteins by Western blot analysis of lysates from organoids after 6 h of
LPS stimulation. Densitometric quantification normalized to GAPDH was calculated as change from the unstimulated control.
RD= relative density %. Stimulated versus unstimulated values were compared using unpaired t-tests. Welch’s correction was used in case
of unequal variances. One-way analysis of variance followed by Dunnett’s multiple comparisons was performed. Each knockout genotype
was compared to WT. ∗∗P < 0:01, ∗∗∗P < 0:001.
6 Stem Cells International
components. We assume that the drop in Ki67, Lgr5, and
Smoc2 expression after day 5 resulted from consumption
of the differentiation inhibitor Y-27632. After a media
exchange, organoids proliferated once more and formed
more crypts. Eleven days after seeding, organoids began to
break open, and by day 13, they were almost uniformly dis-
rupted. In another study by Thalheim et al. [27] investigating
the growth pattern of intestinal organoids, an equilibrium in
the different epithelial cell type fractions was reached after 10
days. When we observed our organoids after 10 days, LGR5-
LPS: – + – + – + – +
WT Il10-/-Cd14-/- Alpk1-/-
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Figure 4: Expression of proinflammatory mediators after LPS stimulation. Changes in gene expression of cytokines and their supernatant
concentration from organoids stimulated with LPS for 6 hours were analysed. Knockout organoids were compared to wild type (WT).
Values are normalized to unstimulated controls within each genotype for each experiment and represent the means with 95% CI.
Unstimulated: WT n = 4‐10, Il10-/- n = 11, Cd14-/- n = 7‐14, and Alpk1-/- n = 4‐8. Stimulated: WT n = 9‐13, Il10-/- n = 11‐14, Cd14-/- n = 8‐13,
and Alpk1-/- n = 6‐9. (a) Tnfα/TNFα, (b) Cxcl1/CXCL1, (c) Cxcl2/CXCL2, and (d) Cxcl5/CXCL5. Stimulated versus unstimulated values
were compared using unpaired t-tests. In the case of unequal variances, Brown-Forsythe and Welch ANOVA test was performed. In all
other cases, a one-way analysis of variance followed by Dunnett’s multiple comparisons was performed. Each knockout genotype was
compared to WT. ∗P < 0:05, ∗∗P < 0:01, ∗∗∗P < 0:001, and ∗∗∗∗P < 0:0001.
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and KI67-positive IECs were at the base of crypts indicating
proliferating stem cell populations. Both enterocyte and
mucus-producing goblet cell population were observed by
H&E staining, immunofluorescence, and cellular junction
staining, and intestinal desquamation and cell turnover were
visible. Therefore, we chose day 10 to begin our stimulation
and infection experiments since at this time point colonic
organoids were viable, differentiated, and demonstrated
mature cellular junctions and crypt-villus structure.
IEC is primarily exposed to bacteria and LPS on their api-
cal surface; however, the basolateral surface is also exposed
when the barrier is compromised or upon infection with
invasive pathogens. Several studies have observed an effect
of physiological concentrations of basally and apically
applied LPS on IEC TJ permeability [28–30]. The way of
infection in 3D organoids is dependent on the regarded
strain [31]. In a study of Sabharwal et al. in 2016, polarized
T84 cells were infected with EcN [32]. Apical EcN infection
triggered only a slight upregulation of Cxcl1 and an addi-
tional downregulation of Il8 expression. When infecting
from the basolateral side, EcN greatly enhanced expression
of Il8 and Cxcl1 [32]. In our organoid system, stimulation
and infection is performed on the basolateral surface as
EcN infection triggers epithelial activation at this site.
LPS is a pathogen-associated molecular pattern that is
recognized by TLR4/CD14. Signalling via TLR4/CD14 leads
to NF-κB activation and subsequent proinflammatory gene
expression [33]. In our study, we used a LPS concentration
of 0.1μg/ml, which was previously shown to induce an epi-
thelial response in vitro [11]. After 6 hours of LPS stimulation
or EcN infection, all organoid lines (WT, Cd14-/-, Il10-/-, and
Alpk1-/-) had increased expression of Tnfα, proving a pos-
itive reaction to the stimulus. However, the increase in
Tnfα/TNFα expression in the Cd14-/- organoids was lower
compared to WT organoids, validating the role of CD14 in
LPS-triggered proinflammatory signalling [20].
ALPK1 does not recognize LPS itself but rather a meta-
bolic intermediate involved in LPS biosynthesis. Accordingly,
our results confirmed that the lack of ALPK1 barely affects
IEC proinflammatory response to LPS exposure alone, as
TNFα expression was similar compared to LPS-stimulated
WT cells. Upon bacterial infection of IECs, ALPK1 has been
shown to signal through TRIF/TRAF6 to NF-κB, triggering
secretion of proinflammatory cytokines like IL8 and TNFα
[34]. However, upregulation of chemokine Cxcl1 and Cxcl5
was significantly less in Alpk1-/- organoids infected with
EcN compared to WT organoids, but an Alpk1 knockout
did not result in decreased levels of proinflammatory media-
tors in the supernatants upon bacterial stimulation of colonic
organoids. Therefore, in our experimental setup, the lack of
ALPK1 did not result in decreased levels of proinflammatory
mediators suggesting a minor role of the ALPK1 signalling
pathway in epithelial cells.
Upon LPS stimulation of WT organoids, we did not
observe changes in the expression of TJ component genes
Ocln, Tjp1, or Cldn8 but did record a significant increase in
Cldn4 expression. EcN infection of WT organoids increased
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Figure 5: Expression of tight junction genes after E. coliNissle stimulation. Wild-type (WT) and knockout organoids were stimulated with E.
coliNissle 1917 for 6 hours and analysed for changes in tight junction component gene and protein expression. Differences between knockout
and WT organoids were investigated. Values were normalized to unstimulated controls within each genotype for each experiment and
represent the means with 95% CI. Unstimulated: WT n = 3‐30, Cd14-/- n = 3‐11, Il10-/- n = 3‐9, and Alpk1-/- n = 3‐9. Stimulated: WT n = 6
‐29, Cd14-/- n = 3‐12, Il10-/- n = 3‐8, and Alpk1-/- n = 3‐9. (a) Gene expression. RQ= relative quantification. (b) Detection of TJ proteins by
Western blot analysis of lysates from organoids after 6 h of EcN stimulation. Densitometric quantification normalized to GAPDH was
calculated as change from the unstimulated control. RD= relative density %. Stimulated versus unstimulated values were compared using
unpaired t-tests. Welch’s correction was used in case of unequal variances. One-way analysis of variance followed by Dunnett’s multiple
comparisons was performed. Each knockout genotype was compared to WT. ∗P < 0:05, ∗∗P < 0:01, ∗∗∗P < 0:001, and ∗∗∗∗P < 0:0001.
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these bacteria on the IEC barrier. Protein levels of occludin
showed no differences in WT, Il10-/-, and Cd14-/- organoids
suggesting a delay in TJ regulation. However,Ocln expression
was significantly reduced in Cd14-/- organoids upon LPS
exposure. Furthermore, Cd14-/- organoids tend to have lower
expression levels of Cldn4 upon LPS stimulation. As occludin
plays an important role in the stability of tight junctions,
these gene expression data support earlier findings of our
group showing a protective role for CD14 in the intestinal
barrier function [11]. A similar decrease in TJ component
gene expression was not seen in Cd14-/- organoids with EcN
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Figure 6: Expression of proinflammatory mediators after E. coli Nissle stimulation. Changes in gene expression of cytokines and their
supernatant concentration after 6 hours of E. coli Nissle 1917 (EcN) stimulation were compared between wild-type (WT) and knockout
organoids. Values were normalized to unstimulated controls within each genotype for each experiment and represent the means with 95%
CI. Unstimulated: WT n = 6‐30, Cd14-/- n = 6‐11, Il10-/- n = 9, and Alpk1-/- n = 9. Stimulated: WT n = 6‐27, Il10-/- n = 8‐9, Cd14-/- n = 6‐12,
and Alpk1-/- n = 6‐9. (a) Tnfα/TNFα, (b) Cxcl1/CXCL1, (c) Cxcl2/CXCL2, and (d) Cxcl5/CXCL5. Stimulated versus unstimulated values
were compared using unpaired t-tests. Welch’s correction was used in case of unequal variances. One-way analysis of variance followed by
Dunnett’s multiple comparisons was performed. Each knockout genotype was compared to WT. ∗P < 0:05, ∗∗P < 0:01, ∗∗∗P < 0:001, and
∗∗∗∗P < 0:0001.
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presentation to TLR4/CD14. As we have shown in vivo,
epithelial-immune cell crosstalk could be necessary for
CD14-dependent impairment of the intestinal barrier upon
EcN infection [12, 35]. Alternatively, other PRRs like TLR2
may be compensating for the lack of CD14 [36].
In addition, infection with whole Gram-negative bacteria
revealed a significant increase in all analysed TJ proteins in
Alpk1-/- organoids, while RNA expression levels of Tjp1
and Cldn8 were decreased. These results indicate that ALPK1
plays an important role regulating tight junction component
expression in IECs which could, in turn, lead to an altered
IEC barrier. In contrast, ALPK1 did not affect the nonhema-
topoietic compartment in a H. hepaticus-induced colitis
mouse model. Rather, ALPK1 influenced the regulation of
IL12 production in bone marrow-derived macrophages [13].
Our group previously described Alpk1 as a Cdcs1 locus
candidate gene for IL10 deficiency-induced colitis severity
in mice [4] and recently excluded a T cell-dependent role
for ALPK1 in colitis progression [5]. Our present study
shows an influence of Alpk1 on epithelial barrier compo-
nents in response to EcN and therefore perhaps to tolerance
to commensal bacteria. A defect in Alpk1 could therefore
contribute to a disruption of barrier function upon bacterial
infection and be a cause for exacerbation of colitogenic
inflammation. Future studies concerning IBD and intestinal
barrier integrity should therefore investigate whether Alpk1-
dependent signalling is involved in disease progression.
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Supplementary Materials
Supplemental Figure 1: detection of TJ proteins by Western
blot analysis of lysates from organoids after 6 h of LPS stim-
ulation (A) and EcN stimulation (B). (A) Samples were
loaded in a random order as follows from left to right: mem-
brane 1: WT control, Il10-/-+LPS, WT+LPS, Il10-/- control,
Cd14-/- control, Il10-/- control, Cd14-/- control, Cd14-/- con-
trol, Il10-/- control; membrane 2: WT+LPS, WT+LPS, WT
control, WT control, Cd14-/-+LPS, Il10-/-+LPS, Il10-/-+LPS,
Cd14-/-+LPS, Cd14-/-+LPS; membrane 3: occludin: WT con-
trol, WT LPS, Cd14-/- control, Cd14-/-+LPS, Il10-/- control,
Il10-/-+LPS, Alpk1-/- control, Alpk1-/-+LPS, WT+LPS; TJP1,
claudin 4, claudin 8, and GAPDH: Alpk1-/- control, Alpk1-
/-control, Alpk1-/- control, Alpk1-/-+LPS, Alpk1-/-+LPS,
Alpk1-/-+LPS. (B) Samples were loaded as follows from left
to right: WT control, WT+EcN, Cd14-/- control, Cd14-/-+
EcN, Il10-/- control, Il10-/-+EcN, Alpk1-/- control, Alpk1-/-+
EcN, WT+EcN. (Supplementary Materials)
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